![Ingrid Müller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ingrid Müller
Director de Operaciones en
EVOTEC SE
.
Perfil
Ingrid Müller is Chief Operating Officer at Evotec SE since 2026.
Dr. Müller was Vice President-Portfolio Strategy & Execution at CureVac NV from 2024 to 2026.
Cargos activos de Ingrid Müller
| Empresas | Cargo | Inicio |
|---|---|---|
| EVOTEC SE | Director de Operaciones | 01/05/2026 |
Antiguos cargos conocidos de Ingrid Müller.
| Empresas | Cargo | Fin |
|---|---|---|
| CUREVAC | Corporate Officer/Principal | 01/01/2026 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
20
Relaciones de 1er grado
2
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
- Bolsa de valores
- Insiders
- Ingrid Müller
